Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Newman’s Own, Inc. Issues Voluntary Recall of Newman’s Own Lite Honey Mustard Dressing Due to Undeclared Milk

By Pharmaceutical Processing | November 26, 2012

 

FDA posts press releases and other
notices of recalls and market withdrawals from the firms involved
as a service to consumers, the media, and other interested parties.
FDA does not endorse either the product or the company.

 

 

Contact:

Consumer:

Anna Harding

203-222-0136 Ext. 49


[email protected]

Media:

Kate Nolan Clemens

860-657-0600

[email protected]

FOR IMMEDIATE RELEASE
– November 23, 2012 – Newman’s Own, Inc. announced the
voluntary recall of Newman’s Own Lite Honey Mustard Dressing
because it contains undeclared milk. People who have an allergy or
severe sensitivity to milk run the risk of a serious or life
threatening allergic reaction if they consume the Newman’s
Own Lite Honey Mustard Dressing with the affected time code. No
other Newman’s Own products or flavors are impacted.

The products are sold in retail stores
in the Eastern to Midwestern US. The affected packages are 16 fl.
oz. bottles of Newman’s Own Lite Honey Mustard Dressing that
have a sell-by date of 16 OCT 13 M with a time stamp from 12:47
– 13:30 and UPC code of 0 20662 00292 1 . The sell-by date is
located on the neck label of the bottle. Only the product with time
codes from 12:47 to 13:30 are affected.

No complaint of illness has been
reported to date.

The recall was initiated after it was
discovered that Newman’s Own Lite Honey Mustard Dressing was
labeled with an incorrect back label that did not list the allergen
milk. Consumers with any product noted above can return the product
to retailer for a full refund, or contact Newman’s Own,
Inc.

##

SOURCE

Related Articles Read More >

kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Disposable syringe and American currency on black background
PBMs increasingly under fire in drug-pricing battle
Johnson & Johnson logo
Timeline: Navigating Johnson & Johnson’s talc lawsuits and their stock performance impact
pharmaceutical industry. Production line machine conveyor with glass bottles ampoules at factory
5 core trends in drug recalls: An analysis of 2022 and Q1 2023
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE